Quantitative structure-activity relationship studies of threo-methylphenidate analogs

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Pharmacology

Background:

• Dopamine transporter (DAT) is a key target for treating conditions like ADHD.
• Methylphenidate (MP) analogs are widely studied for their DAT binding properties.
• Predictive modeling can accelerate the discovery of novel DAT inhibitors.

Purpose of the Study:

• To develop preliminary Quantitative Structure-Activity Relationship (QSAR) models for predicting DAT binding affinity.
• To identify key structural features of methylphenidate analogs that influence DAT binding.
• To guide the rational design of new compounds with improved DAT affinity.

Main Methods:

• Employed complementary 2D and 3D QSAR techniques, including Comparative Molecular Field Analysis (CoMFA).
• Utilized atom-level E-state indices and a sphere exclusion protocol for test set selection.
• Applied partial least squares analysis with Molconn-Z descriptors for 2D-QSAR validation.

Main Results:

• CoMFA models revealed that steric bulk at the 2' position of the phenyl ring reduces DAT binding.
• Electron-withdrawing groups at the 3' or 4' positions of the phenyl ring enhance DAT binding affinity.
• Optimal substituents possess bulk primarily within the plane of the phenyl ring, such as halogen substituents.

Conclusions:

• Phenyl ring substitution is a critical determinant of DAT binding affinity.
• The developed QSAR models accurately predict binding affinity and can guide the design of novel DAT ligands.
• Suggested modifications include incorporating electron-withdrawing groups at specific phenyl ring positions to optimize binding.